Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,710,978
+$3,890,805 QoQ
Shares Held
2,688,359
-12.4% QoQ
Ownership
2.56%
of shares outstanding
% of Portfolio
2.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Sep 30, 2022CallValue
$28,701,606
CallShares
775,300
PutValue
$28,701,606
PutShares
775,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ikarian Capital, LLC holds $657,306,791 across 105 Biotechnology names. RLMD ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
1,456,378 | $76,780,248 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,265,795 | $48,252,105 | |
| 3 | ALMS |
Alumis Inc.
|
1,213,548 | $26,734,462 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
428,682 | $24,910,711 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
71,581 | $23,062,682 | |
| 6 | RLMD |
Relmada Therapeutics, Inc.
This page
|
2,688,359 | $18,710,978 | |
| 7 | CYTK |
Cytokinetics Inc
|
283,572 | $18,690,230 | |
| 8 | TENX |
Tenax Therapeutics, Inc.
|
1,017,600 | $16,271,424 |
All Filings in RLMD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,710,978 | 2,688,359 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,820,173 | 3,068,359 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $3,704,550 | 1,843,060 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,162 | 40,270 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,872 | 40,270 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,940 | 40,270 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $130,795 | 40,369 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $121,107 | 40,369 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $187,715 | 40,369 | Shares | Sole | 2024-05-17 | |
| 2023-12-31 | $167,127 | 40,369 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $121,107 | 40,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $161,107 | 65,491 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $148,009 | 65,491 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $228,563 | 65,491 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,701,606 | 775,300 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $28,701,606 | 775,300 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $5,360,877 | 282,300 | Put | Sole | 2022-08-12 | |
| 2022-06-30 | $5,697,000 | 300,000 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $588,408 | 21,801 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $467,339 | 20,743 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $543,674 | 20,743 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,609,626 | 300,207 | Shares | Sole | 2021-08-18 | |
| 2021-06-30 | $6,510,834 | 203,400 | Call | Sole | 2021-08-18 | |
| 2021-03-31 | $6,957,496 | 197,600 | Call | Sole | 2021-08-18 | |
| 2021-03-31 | $10,218,188 | 290,207 | Shares | Sole | 2021-08-18 | |
| 2020-03-31 | $1,881,916 | 55,172 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||